Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3518-3525

  Chen, Gin Fu ^a,e   Wagner, Laszlo ^a,d   Sasser, Jennifer M ^a   Zharikov, Sergey ^b,c   Moningka, Natasha C ^a   Baylis, Chris ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Arginase; DDAH; Irbesartan; Kidney disease; Olmesartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGINASE; ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; CASEIN; CITRULLINE; DIMETHYLARGININASE; DIMETHYLARGININASE 1; DIMETHYLARGININASE 2; IRBESARTAN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OLMESARTAN; UNCLASSIFIED DRUG; AMIDASE; BIPHENYL DERIVATIVE; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; TETRAZOLE DERIVATIVE;

AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FAWN HOODED HYPERTENSIVE RAT; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HYPERTENSION; INHIBITION KINETICS; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; ANIMAL; BIOSYNTHESIS; METABOLISM;

AMIDOHYDROLASES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARGININE; BIPHENYL COMPOUNDS; CITRULLINE; HYPERTENSION; MALE; METABOLIC NETWORKS AND PATHWAYS; NITRIC OXIDE; RATS; TETRAZOLES;

EID: 79952200255     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq272     Document Type: Article

References (42)

1. Aiello S, Noris M, Todeschini M et al. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 1997; 52: 171-181 (Pubitemid 27321828)
2. Blum M, Yachnin T, Wollman Yet al. Low nitric oxide production in patients with chronic renal failure. Nephron 1998; 79: 265-268 (Pubitemid 28310329)
3. Morris SM. Arginine: Beyond protein. Am J Clin Nutr 2006; 83: 508S-512S
4. Wu G, Morris SM Jr. Arginine metabolism: Nitric oxide and beyond. Biochem J 1998; 336: 1-17 (Pubitemid 28532555)
5. Vallance P, Leone A, Calver A et al. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20: S60-S62 (Pubitemid 23014109)
6. Achan V, Broadhead M, Malaki M et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003; 23: 1455-1459 (Pubitemid 36994536)
7. Mattson DL, Dwinell MR, Greene AS et al. Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats. Am J Physiol Ren Physiol 2007; 293: F1905-F1914 (Pubitemid 350179615)
8. Van Dokkum RP, Jacob HJ, Provoost AP. Genetic differences define severity of renal damage after L-NAME-induced hypertension in rats. J Am Soc Nephrol 1998; 9: 363-371
9. Koeners MP, Braam B, van der Giezen DM et al. A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1847-R1855
10. Verseput GH, Koomans HA, Braam B et al. ACE inhibition delays development of terminal renal failure in the presence of severe albuminuria. Am J Kidney Dis 2000; 35: 202-210 (Pubitemid 30070840)
11. Verseput GH, Braam B, Provoost AP et al. Tubuloglomerular feedback and prolonged ACE-inhibitor treatment in the hypertensive fawn-hooded rat. Nephrol Dial Transplant 1998; 13: 893-899 (Pubitemid 28161760)
12. Verseput GH, Provoost AP, Braam BB et al. Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat. J Am Soc Nephrol 1997; 8: 249-259 (Pubitemid 127455880)
13. Verseput GH, Provoost AP, van Tol A et al. Hyperlipidemia is secondary to proteinuria and is completely normalized by angiotensinconverting enzyme inhibition in hypertensive fawn-hooded rats. Nephron 1997; 77: 346-352 (Pubitemid 27477695)
14. Ziai F, Ots M, Provoost AP et al. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney Int Suppl 1996; 57: S132-S136 (Pubitemid 26418481)
15. Tsikas D, Wolf A, Frolich JC. Simplified HPLC method for urinary and circulating creatinine. Clin Chem 2004; 50: 201-203 (Pubitemid 38125719)
16. Sasser JM, Moningka NC, Cunningham MW Jr et al. Asymmetric dimethylarginine in angiotensin II induced hypertension. Am J Physiol Regul Integr Comp Physiol 2009; 298: R740-R746
17. Heresztyn T, Worthley MI, Horowitz JD. Determination of l-arginine and NG, NG- and NG, NG'-dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 805: 325-329 (Pubitemid 38596755)
18. Tain YL, Baylis C. Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Int 2007; 72: 886-889 (Pubitemid 47462078)
19. Tain Y-L, Freshour G, Dikalova A et al. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Ren Physiol 2007; 292: 1404-1410
20. Suto T, Losonczy G, Qiu C et al. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 1995; 48: 1272-1277
21. Yu Y, Terada K, Nagasaki A et al. Preparation of recombinant argininosuccinate synthetase and argininosuccinate lyase: Expression of the enzymes in rat tissues. J Biochem 1995; 117: 952-957
22. Zharikov S, Krotova K, Hu H et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 2008; 295: C1183-C1190 (Pubitemid 352790338)
23. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137-143 (Pubitemid 14017051)
24. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine-what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 1998; 7: 59-62 (Pubitemid 28037522)
25. Lopez B, Ryan RP, Moreno C et al. Identification of a QTL on chromosome 1 for impaired autoregulation of RBF in fawn-hooded hypertensive rats. Am J Physiol Ren Physiol 2006; 290: F1213-F1221 (Pubitemid 43724922)
26. Van Dijk SJ, Specht PA, Lutz MM et al. Interaction between Rf-1 and Rf-4 quantitative trait loci increases susceptibility to renal damage in double congenic rats. Kidney Int 2005; 68: 2462-2472 (Pubitemid 43250993)
27. Simons JL, Provoost AP, De Keijzer MH et al. Pathogenesis of glomerular injury in the fawn-hooded rat: Effect of unilateral nephrectomy. J Am Soc Nephrol 1993; 4: 1362-1370
28. van Dokkum RP, Sun CW, Provoost AP et al. Altered renal hemodynamics and impaired myogenic responses in the fawn-hooded rat. Am J Physiol 1999; 276: R855-R863 (Pubitemid 29157517)
29. Chen GF, Baylis C. In vivo renal arginine release is impaired throughout development of chronic kidney disease. Am J Physiol Ren Physiol 2010; 298: F95-F102
30. Peyton KJ, Ensenat D, Azam MA et al. Arginase promotes neointima formation in rat injured carotid arteries. Arterioscler Thromb Vasc Biol 2009; 29: 488-494
31. Wei LH, Wu G, Morris SM Jr et al. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci USA 2001; 98: 9260-9264 (Pubitemid 32743904)
32. Rodriguez S, Richert L, Berthelot A. Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats. Clin Exp Hypertens 2000; 22: 75-85 (Pubitemid 30090949)
33. Lim HK, Ryoo S, Benjo A et al. Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol 2007; 293: H3317-H3324 (Pubitemid 350230871)
34. Li H, Meininger CJ, Hawker JR et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 2001; 280: 75-82
35. Hultstrom M, Helle F, Iversen BM. AT(1) receptor activation regulates the mRNA expression of CAT1, CAT2, arginase-1, and DDAH2 in preglomerular vessels from angiotensin II hypertensive rats. Am J Physiol Ren Physiol 2009; 297: F163-F168
36. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Ren Physiol 2008; 294: F1-F9
37. Vallance P, Leiper J. Asymmetric dimethylarginine and kidney disease-marker or mediator? J Am Soc Nephrol 2005; 16: 2254-2256 (Pubitemid 41725041)
38. Boger RH, Zoccali C. ADMA: A novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler Suppl 2003; 4: 23-28 (Pubitemid 38234491)
39. Zoccali C, Bode-Boger S, Mallamaci F et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 2001; 358: 2113-2117 (Pubitemid 34094901)
40. Palm F, Onozato ML, Luo Z et al. Dimethylarginine dimethylaminohydrolase (DDAH): Expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2007; 293: H3227-H3245 (Pubitemid 350230862)
41. Ulu N, Schoemaker RG, Henning RH et al. Proteinuria-associated endothelial dysfunction is strain dependent. Am J Nephrol 2009; 30: 209-217
42. Weichert W, Paliege A, Provoost AP et al. Upregulation of juxtaglomerular NOS1 and COX-2 precedes glomerulosclerosis in fawnhooded hypertensive rats. Am J Physiol Ren Physiol 2001; 280: F706-F714